Filing Details
- Accession Number:
- 0000874716-24-000144
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-29 17:00:08
- Reporting Period:
- 2024-11-27
- Accepted Time:
- 2024-11-29 17:00:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1442078 | V. Sophie Vandebroek | One Idexx Drive Westbrook ME 04092 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-11-27 | 224 | $0.00 | 1,249 | No | 4 | G | Direct | |
| Common Stock | Disposition | 2024-11-27 | 344 | $420.44 | 905 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | G | Direct | |
| No | 4 | S | Direct |
Billionaire Hedge Funds
